1. Effects of Vitamin D Supplementation on Cardiovascular and Glycemic Biomarkers.
- Author
-
Miao, Jennifer, Bachmann, Katherine, Huang, Shi, Su, Yan, Dusek, Jeffery, Newton-Cheh, Christopher, Arora, Pankaj, and Wang, Thomas
- Subjects
high‐sensitivity C‐reactive protein ,insulin resistance ,lipids ,meta‐analysis ,vitamin D ,Adolescent ,Adult ,Biomarkers ,Blood Glucose ,Cardiovascular Diseases ,Dietary Supplements ,Dose-Response Relationship ,Drug ,Double-Blind Method ,Female ,Humans ,Insulin Resistance ,Lipids ,Male ,Middle Aged ,Vitamin D ,Vitamins ,Young Adult - Abstract
Background Experimental and observational studies have suggested a link between vitamin D and cardiovascular and metabolic disease, but this has not been confirmed in randomized controlled trials. We sought to determine whether vitamin D supplementation reduces biomarkers of insulin resistance, inflammation, neurohormonal activation, and lipids. Methods and Results This was a prespecified, secondary analysis of the DAYLIGHT (Vitamin D Therapy in Individuals at High Risk of Hypertension) randomized controlled trial. We measured circulating homeostatic model assessment of insulin resistance, hs-CRP (high-sensitivity C-reactive protein), N-terminal pro-B-type natriuretic peptide, renin, aldosterone, and lipids at baseline and at 6 months in 289 individuals with low vitamin D status (25-hydroxyvitamin-D [25-OH-D] ≤25 ng/mL) receiving low-dose (400 IU/d) versus high-dose (4000 IU/d) vitamin D3 for 6 months. A meta-analysis of randomized controlled trials reporting biomarker changes after vitamin D supplementation was then performed. Levels of 25-OH-D increased in the high-dose relative to the low-dose vitamin D group (+15.5 versus +4.6 ng/mL, P
- Published
- 2021